TY - JOUR
T1 - Biological activity of enantiomeric complexes [PtCl2L 2] (L2 is aromatic bisphosphanes and aromatic diamines)
AU - Bombard, Sophie
AU - Gariboldi, Marzia Bruna
AU - Monti, Elena
AU - Gabano, Elisabetta
AU - Gaviglio, Luca
AU - Ravera, Mauro
AU - Osella, Domenico
N1 - Funding Information:
Acknowledgments Financial support for this work was provided by the Regione Piemonte (CIPE project-code A 370 and Ricerca Sanitaria Finalizzata 2009), ATF Association (Alessandria, Italy), CNRS, and ARC 4835 (Paris, France). The study was carried out within the framework of the European Cooperation COST D39 (Metallo-Drug Design and Action) and Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCMSB, Bari, Italy). We are indebted to Cristina Prandi (University of Turin, Italy) for her assistance in measuring optical rotatory power.
PY - 2010/8
Y1 - 2010/8
N2 - Enantiomeric complexes of formula [PtCl 2L 2] [L 2 is (R)-(+)-BINAP and (S)-(-)-BINAP, where BIN-AP is 2,2'-bis(diphenylphosphane)-1,1'-binaphthyl, and (R)-(+)-DABN and (S)-(-)-DABN, where DABN is 1,1'-binaphthyl-2,2'-diamine], were tested for their cytotoxic activity against three cancer cell lines and for their ability to bind to the human telomeric sequence folded in the G-quadruplex structure. Similar experiments were carried out on prototypal complexes cisplatin and cis-[PtCl 2(PPh 3) 2] for comparison. Platinum complexes containing phosphanes proved less cytotoxic to cancer cell lines and less likely to interact with the nucleobases of the G-quadruplex than those containing amines; in both cases the S-(-) isomer was more active than the R-(+) counterpart. More specifically, whereas all the platinum complexes were abletoplatinate the G-quadruplex structure from the human telomeric repeat, the extent and sites of platination depended on the nature of the ligands. Complexes containing (bulky) phosphanes interacted only with the adenines of the loops, whereas those containing the less sterically demanding amines interacted with adenines and some guanines of the G-quartet.
AB - Enantiomeric complexes of formula [PtCl 2L 2] [L 2 is (R)-(+)-BINAP and (S)-(-)-BINAP, where BIN-AP is 2,2'-bis(diphenylphosphane)-1,1'-binaphthyl, and (R)-(+)-DABN and (S)-(-)-DABN, where DABN is 1,1'-binaphthyl-2,2'-diamine], were tested for their cytotoxic activity against three cancer cell lines and for their ability to bind to the human telomeric sequence folded in the G-quadruplex structure. Similar experiments were carried out on prototypal complexes cisplatin and cis-[PtCl 2(PPh 3) 2] for comparison. Platinum complexes containing phosphanes proved less cytotoxic to cancer cell lines and less likely to interact with the nucleobases of the G-quadruplex than those containing amines; in both cases the S-(-) isomer was more active than the R-(+) counterpart. More specifically, whereas all the platinum complexes were abletoplatinate the G-quadruplex structure from the human telomeric repeat, the extent and sites of platination depended on the nature of the ligands. Complexes containing (bulky) phosphanes interacted only with the adenines of the loops, whereas those containing the less sterically demanding amines interacted with adenines and some guanines of the G-quartet.
KW - Cytotoxicity
KW - DNA quadruplex
KW - Phosphanes and amines
KW - Platinum complexes
KW - Telomere
UR - https://www.scopus.com/pages/publications/77956471531
U2 - 10.1007/s00775-010-0648-8
DO - 10.1007/s00775-010-0648-8
M3 - Article
SN - 0949-8257
VL - 15
SP - 841
EP - 850
JO - Journal of Biological Inorganic Chemistry
JF - Journal of Biological Inorganic Chemistry
IS - 6
ER -